Company: PFSA
Filing Date: 2025-05-15
Form Type: 424B3
Source: 0001213900-25-044417
Chunk: 462

Company: Profusa, Inc.
Filing Date: 2025-05-15
Form: 424B3
Chunk 462
---
 animal models. Furthermore, we also performed research and development under government grants. Since inception, we have incurred recurring annual losses from operations. For the years ended December 31, 2024 and 2023, we incurred a net loss of $9.2 million and $10.3 million, respectively. During the years ended December 31, 2024 and 2023, we have used $2.1 million and $4.4 million, respectively, of cash in our operating activities. We have notes and loans payable and interest due of $48.2million within one year of December31, 2024. We have been able to finance our operations primarily with the proceeds from the issuance of equity and debt instruments and to a lesser extent, revenues from government grants. For the year ending December 31, 2024, we obtained net cash from financing activities of $2.1 million compared to $4.5 million for the same period in 2023. We held cash of $0.2million and $0.1 million as of December 31, 2024 and 2023, respectively. Additional funds may be necessary to maintain current operations and will be required for successful product commercialization efforts. Our management plans to monitor expenses and obtain additional funds through public or private equity offerings or debt financings, additional credit or loan facilities or a combination of one or more of these funding sources, which is intended to mitigate the relevant conditions or events that raise substantial doubt about our ability to continue as a going concern within one year from the date the audited consolidated financial statements are issued. As the ability to refinance our current debt or raise additional equity financing is outside of our management’s control, we cannot conclude that management’s plans will be effectively implemented within one year from the date the audited consolidated financial statements are issued. These factors raise substantial doubt about our ability to continue as a going concern within one year from the date the audited consolidated financial statements are issued. The audited consolidated financial statements do not contain any adjustments that might result from the outcome of this uncertainty. It is our expectation to continue to make substantial investments in building its European and United States commercial infrastructure and enhancing existing products and developing new ones. Furthermore, we aim to continue discussions with potential partners in Asia. We expect to incur additional expenses due to operating as a public company, including expenses related to compliance with the rules and regulations of the U.S. Securities and Exchange Commission, or the SEC, and those of the Nasdaq Stock